Delivery Order SPE2DB22D3010-SPE2DB24FP2MQ
- Not listed
- This federal contract award, valued at $9,653.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CYCLOSPORINE 0.05% EYE EMULS 60S, a pharmaceutical product, with a completion date of January 15, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,758.35 firm fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, with an ultimate completion date of November 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,525.76 firm fixed-price delivery order is for the supply of CYCLOSPORINE 0.05% EYE EMULSION 60S, a specialty ophthalmic medication. The award has an ultimate completion date of March 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $2,632.25, is a delivery order for the supply of CYCLOSPORINE 0.05% EYE EMULS 30S, a prescription eye medication. The contract has a completion date of September 4, 2024 and is a Firm Fixed Price contract. This award is associated with a larger Indefinite Delivery Contract...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,155.81 firm fixed-price delivery order is for the supply of 4564545047 - CYCLOSPORINE 0.05% EYE EMULS 60S, a pharmaceutical product. This award is not designated as a set-aside contract. The contract has an ultimate completion date of May 9, 2024 and was awarded on May 8, 2024. AmerisourceBergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,034.20 firm fixed-price delivery order is for the supply of CYCLOSPORINE 0.05% EYE EMULS 60S, a specialty pharmaceutical product. The award has an ultimate completion date of January 9, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of cyclosporine 0.05% eye emulsion. The contract, valued at $8,917.01, is a Firm Fixed Price Delivery Order with a completion date of September 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $11,841.14 and covers the delivery of 4563692976 CYCLOSPORINE 0.05% EYE EMULS 60S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of February 20, 2024. This award is associated with a larger Indefinite Delivery...
- This federal contract award, valued at $7,334.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cyclosporine 0.05% Eye Emulsion, a specialty pharmaceutical product, with an ultimate completion date of November 5, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,728.40 firm-fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion medication, with a completion date of June 30, 2023. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB24FP2MQDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,557.90 firm fixed-price delivery order contract is for the supply of CYCLOSPORINE 0.05% EYE EMULS 30S, a medical product. The contract has a completion date of May 30, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 5/29/24 |